Brief: Cadrenal Therapeutics Inc Says On Sept 6, Co Got Letter From Nasdaq Stating That Co Was Not In Compliance With Nasdaq Listing Rule
08/09/2023 21:12
Sept 8 (Reuters) - Cadrenal Therapeutics Inc CVKD.O :
* CADRENAL THERAPEUTICS INC - ON SEPT 6, CO GOT LETTER FROM
NASDAQ
STATING THAT CO WAS NOT IN COMPLIANCE WITH NASDAQ LISTING RULE
Further company coverage: CVKD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cadrenal Therapeutics
See all newsCadrenal Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Cadrenal Therapeutics Q2 net loss narrows as operating expenses fall
Cadrenal Therapeutics Inc expected to post a loss of $1.42 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Marvell Technology